Corbus Pharmaceuticals

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Mon, 02/13/23 - 10:29 am
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
3 Biotech Stocks With Big Catalysts in June
Motley Fool
Tue, 06/22/21 - 10:55 am
Corbus Pharmaceuticals
lenabasum
clinical trials
Gemini Therapeutics
age-related macular degeneration
Intellia Therapeutics
hATTR-pn
Corbus craters on ‘surprising’ late-stage lenabasum flop
Fierce Biotech
Tue, 09/8/20 - 10:27 pm
Corbus Pharmaceuticals
cutaneous systemic sclerosis
clinical trials
lenabasum
Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Fierce Biotech
Wed, 03/11/20 - 10:55 am
clinical trials
Gilead Sciences
Galapagos
Corbus Pharmaceuticals
Intercept Pharmaceuticals
coronaviruses
COVID-19
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 09/22/18 - 05:31 pm
Viking Therapeutics
Acadia Pharmaceuticals
Corbus Pharmaceuticals
Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
Motley Fool
Fri, 09/21/18 - 10:59 pm
Corbus Pharmaceuticals
cannabindoids
drug development
Corbus drug aces second mid-stage trial, this time in cystic fibrosis
Bizjournals.com
Thu, 03/30/17 - 10:04 am
Corbus Pharmaceuticals
clinical trials
cystic fibrosis
anabasum
Inside the small Norwood biotech that's making investors swoon
Bizjournals.com
Fri, 03/17/17 - 09:28 am
Corbus Pharmaceuticals
autoimmune disease
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
4 Ignored Biotech Stocks for 2016
24/7 Wall St
Wed, 12/23/15 - 11:08 am
ANI Pharmaceuticals
Corbus Pharmaceuticals
Geron
Ardelyx
Execs behind Imbruvica raise $75M for a new cancer project
Fierce Biotech
Wed, 09/30/15 - 10:44 am
Imbruvica
Corbus Pharmaceuticals
cancer
What Lit a Fire Under These 3 Pharma Stocks
24/7 Wall St
Sun, 08/23/15 - 11:41 am
Aveo Pharmaceuticals
Omeros
Corbus Pharmaceuticals
Corbus' shares soar on FDA news that could speed up drug approval
Bizjournals.com
Wed, 08/19/15 - 08:52 pm
Resunab
Corbus Pharmaceuticals
FDA
fast track
In the shadow of Vertex, small cystic fibrosis-focused biotechs thrive
Bizjournals.com
Mon, 08/17/15 - 06:19 pm
Vertex Pharmaceuticals
cystic fibrosis
Pulmatrix
Corbus Pharmaceuticals